One example of this resistance to therapy is pancreatic cancer’s varied sensitivity to TRAIL, a tumor-selective cytokine, which activates the extrinsic apoptotic pathway [27–31]. This evidence concerns the gene TNFSF10 and pancreatic neoplasm.